Moderna Tweaks it’s vaccine to deal with one of the Covid variants….

Moderna said Wednesday that it has manufactured a new version of its coronavirus vaccine that is tailored to quell infection by the variant first identified in South Africa. A small amount of vaccine has been sent to the National Institutes of Health for a trial to determine whether boosting humans with the modified vaccine will stimulate a strong immune response, the company said.